TriMas (NASDAQ:TRS) Given “Buy” Rating at BWS Financial

TriMas (NASDAQ:TRS)‘s stock had its “buy” rating restated by research analysts at BWS Financial in a research note issued to investors on Tuesday, Benzinga reports. They presently have a $40.00 target price on the industrial products company’s stock. BWS Financial’s target price would suggest a potential upside of 54.68% from the company’s current price.

TriMas Trading Up 4.0 %

TRS traded up $0.99 during midday trading on Tuesday, reaching $25.86. 160,433 shares of the company were exchanged, compared to its average volume of 264,769. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.48 and a current ratio of 2.82. TriMas has a one year low of $22.45 and a one year high of $28.51. The stock has a market capitalization of $1.05 billion, a P/E ratio of 40.41 and a beta of 0.66. The stock’s 50-day simple moving average is $25.83 and its 200 day simple moving average is $25.82.

TriMas (NASDAQ:TRS) last issued its earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.14). TriMas had a return on equity of 9.61% and a net margin of 4.44%. The company had revenue of $229.36 million for the quarter, compared to the consensus estimate of $239.33 million. During the same quarter last year, the business posted $0.57 EPS. TriMas’s quarterly revenue was down 2.5% on a year-over-year basis. As a group, analysts forecast that TriMas will post 1.75 earnings per share for the current fiscal year.

Institutional Investors Weigh In On TriMas

A number of hedge funds have recently modified their holdings of TRS. Quantbot Technologies LP raised its position in TriMas by 5.7% in the 1st quarter. Quantbot Technologies LP now owns 8,933 shares of the industrial products company’s stock valued at $239,000 after buying an additional 478 shares during the last quarter. Algert Global LLC increased its position in shares of TriMas by 4.2% during the 2nd quarter. Algert Global LLC now owns 15,779 shares of the industrial products company’s stock worth $403,000 after purchasing an additional 639 shares during the last quarter. Rhumbline Advisers increased its position in shares of TriMas by 1.4% during the 2nd quarter. Rhumbline Advisers now owns 69,328 shares of the industrial products company’s stock worth $1,772,000 after purchasing an additional 985 shares during the last quarter. Innealta Capital LLC acquired a new position in shares of TriMas during the 2nd quarter worth approximately $26,000. Finally, Diversified Trust Co increased its position in shares of TriMas by 5.0% during the 2nd quarter. Diversified Trust Co now owns 22,719 shares of the industrial products company’s stock worth $581,000 after purchasing an additional 1,072 shares during the last quarter. Institutional investors and hedge funds own 99.42% of the company’s stock.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.